Search results
Results From The WOW.Com Content Network
The five-year survival rate for endometrial adenocarcinoma following appropriate treatment is 80%. [85] More than 70% of women diagnosed have FIGO stage I cancer, which has the best prognosis. Stage III and especially Stage IV cancers has a worse prognosis, but these are relatively rare, occurring in only 13% of cases.
FIGO stage II or greater is considered advanced with overall survival of approximately 60% with myometrial invasion, but less than 50% if metastases are present. High grade adenosarcomas tend to have extrauterine spread and rapid recurrence. [14] Adenosarcoma with myometrial invasion recurred in 36-46% of cases.
Adenomyoma is a tumor (-oma) including components derived from glands (adeno-) and muscle (-my-). [1] It is a type of complex and mixed tumor, and several variants have been described in the medical literature.
The diagnosis is established when the pathologist finds invading clusters of endometrial tissue within the myometrium. Several diagnostic criterion can be used, but typically they require either the endometrial tissue to have invaded greater than 2% of the myometrium, or a minimum invasion depth between 2.5 and 8mm. [6]
Carcinosarcoma of the uterus. In gross appearance, MMMTs are fleshier than adenocarcinomas, may be bulky and polypoid, and sometimes protrude through the cervical os.On histology, the tumors consist of adenocarcinoma (endometrioid, serous or clear cell) mixed with the malignant mesenchymal elements; alternatively, the tumor may contain two distinct and separate epithelial and mesenchymal ...
An important risk factor for placenta accreta is placenta previa in the presence of a uterine scar. Placenta previa is an independent risk factor for placenta accreta. Additional reported risk factors for placenta accreta include maternal age and multiparity, other prior uterine surgery, prior uterine curettage, uterine irradiation, endometrial ablation, Asherman syndrome, uterine leiomyomata ...
In the older literature survival rates have been given as 35–50% for stage I–II and 0–15% for stage III and IV uterine papillary serous carcinoma, [4] More recently it was reported that forty-two percent of 138 patients were found disease-free at five years.
African American women are two to three times more likely to get fibroids than Caucasian women. [12] [13] [74] In African American women fibroids seem to occur at a younger age, grow more quickly, and are more likely to cause symptoms. [75] This leads to higher rates of surgery for African Americans, both myomectomy, and hysterectomy. [76]